View Cart (0 items)


Pharm industry sales to top $1.2 trillion by 2016

Globalization impacts demand and production of pharmaceuticals
February 5, 2013
Pharmaceutical manufacturers today face a considerable checklist of significant challenges, including the fight against counterfeiting, reducing costs through offshore manufacturing and maintaining product integrity.
Read More

Pharma companies set high hopes for 2013

February 4, 2013
Following the approval of 39 new drugs in 2012, and with a number of new pharmaceutical products already in their final stages of development, global pharma companies are optimistic about the next 12 months.
Read More

FDA to tighten control on painkillers

February 1, 2013
The U.S. Food and Drug Administration (FDA) is considering measures to make prescription drugs more difficult to access in a move to prevent overdoses associated with painkillers like OxyContin and Opana, which killed 16,000 people in 2010 alone.
Read More

Pharmaceutical industry in strategic crisis, report says

January 10, 2013
Increasing price and cost pressure, regulatory changes and expiring patents are leading to shrinking margins in the pharmaceutical industry.
Read More

Operations halted at pharmaceutical plant after discovery of potential explosives

December 5, 2012
A pharmaceuticals factory in Wales has been closed following the discovery of potentially explosive chemicals on site.
Read More

Pfizer to acquire NextWave Pharmaceuticals

November 29, 2012
NEW YORK — Pfizer Inc. has agreed to acquire NextWave Pharmaceuticals, a specialty pharmaceutical company that specializes in products for the treatment of attention deficit/hyperactivity disorder (ADHD) and related
Read More

Dow Chemical collaborates with Bend Research to develop drug-solubility solutions

October 10, 2012
MIDLAND, Mich. and BEND, Ore. — Dow Chemical and drug-formulation development and manufacturing company Bend Research Inc. are collaborating to provide science-based spray-dried dispersion (SDD) solutions and select enabling
Read More

Antares Pharma receives development milestone payment

October 2, 2012
EWING, N.J. -- Antares Pharma, Inc. announced that its partner Pfizer Inc. achieved a development milestone related to its undisclosed Consumer Healthcare product. This development milestone in Antares’ collaboration with Pfizer
Read More

Valeant Pharmaceuticals acquires Visudyne From QLT

September 24, 2012
MONTREAL — Valeant Pharmaceuticals International, Inc. says it has acquired Visudyne, used to treat abnormal growth of leaky blood vessels in the eye caused by wet age-related macular degeneration,
Read More

Bayer HealthCare to acquire Teva U.S. animal health business

September 18, 2012
SHAWNEE, Kan. and JERUSALEM — Bayer HealthCare LLC and Teva Pharmaceutical Industries Ltd. say they have signed an agreement in which Bayer will acquire the U.S. based animal health
Read More